Inflammation

Items 1101-1110 of 1391

per page
Set Descending Direction
  1. EGF (human) (rec.) (His)
    CHI-HF-201EGF
    CHI-HF-201EGF-C01010 µg
    CHF 210.00
  2. EGF (human):Fc (human) (rec.)
    CHI-HF-210EGF
    CHI-HF-210EGF-C100100 µg
    CHF 240.00
  3. EGFR, Soluble (human) (rec.)
    AG-40T-0041
    AG-40T-0041-C02525 µg
    CHF 620.00
  4. Enzolution™ MDA5 ATPase FI Assay System
    BBL-3036-FI
    BBL-3036-FI-1K1000 assays
    CHF 1'010.00
    BBL-3036-FI-10K10000 assays
    CHF 3'418.00
    BBL-3036-FI-100K10 x 10000 assaysINQ
    Enzolution™ MDA5 ATPase FI Assay System
  5. Enzolution™ MDA5 ATPase FP Assay System
    BBL-3036-FP
    BBL-3036-FP-1K1000 assays
    CHF 1'010.00
    BBL-3036-FP-10K10000 assays
    CHF 3'418.00
    BBL-3036-FP-100K10 x 10000 assaysINQ
    Enzolution™ MDA5 ATPase FP Assay System
  6. Enzolution™ MDA5 ATPase TR-FRET Assay System
    BBL-3036-TR
    BBL-3036-TR-1K1000 assays
    CHF 1'010.00
    BBL-3036-TR-10K10000 assays
    CHF 3'418.00
    BBL-3036-TR-100K10 x 10000 assaysINQ
    Enzolution™ MDA5 ATPase TR-FRET Assay System
  7. Enzolution™ RIG-I ATPase FI Assay System
    BBL-3035-FI
    BBL-3035-FI-1K1000 assays
    CHF 927.00
    BBL-3035-FI-10K10000 assays
    CHF 4'673.00
    BBL-3035-FI-100K10 x 10000 assaysINQ
    NEW Enzolution™ RIG-I ATPase FI Assay System
  8. Enzolution™ RIG-I ATPase FP Assay System
    BBL-3035-FP
    BBL-3035-FP-1K1000 assays
    CHF 927.00
    BBL-3035-FP-10K10000 assays
    CHF 4'673.00
    BBL-3035-FP-100K10 x 10000 assaysINQ
    NEW Enzolution™ RIG-I ATPase FP Assay System
  9. Enzolution™ RIG-I ATPase TR-FRET Assay System
    BBL-3035-TR
    BBL-3035-TR-1K1000 assays
    CHF 927.00
    BBL-3035-TR-10K10000 assays
    CHF 4'673.00
    BBL-3035-TR-100K10 x 10000 assaysINQ
    NEW Enzolution™ RIG-I ATPase TR-FRET Assay System
  10. EPO (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-220EPO
    CHI-HF-220EPO-C05050 µg
    CHF 430.00

Items 1101-1110 of 1391

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.